Crescent Biopharma Inc. Company Profile
NASDAQ: CBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Crescent Biopharma at a glance
Crescent Biopharma Inc. (NASDAQ: CBIO) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Waltham, MA. Crescent Biopharma is led by Mr. Joshua T. Brumm and employs about 69 people. The company's shares have traded publicly since 2014.
At a market capitalization of $504.0 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001253689, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Crescent Biopharma do?
Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States. Its pipeline includes CR-001, which is in Phase 3 clinical trial, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics. The company was formerly known as GlycoMimetics, Inc. The company was founded in 2024 and is headquartered in Waltham, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- Crescent Biopharma Inc.
- Ticker
- NASDAQ: CBIO
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Joshua T. Brumm
- Employees
- 69
- Headquarters
- 300 Fifth Avenue, Waltham, MA, United States
- Phone
- 617 460 5595
- Website
- crescentbiopharma.com
- IPO year
- 2014
- Market cap
- $504.04M
- SEC CIK
- 0001253689
Companies similar to Crescent Biopharma
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PBYIPuma Biotechnology Inc | 9.81 | +3.26% | $506.39M | vs CBIO |
| ACRSAclaris Therapeutics Inc. | 3.40 | -8.11% | $500.48M | vs CBIO |
| EOLSEvolus Inc. | 7.74 | +4.88% | $511.23M | vs CBIO |
| DRUGBright Minds Biosciences Inc. | 52.00 | +7.77% | $512.93M | vs CBIO |
| ALTAltimmune Inc. | 2.66 | -0.37% | $517.42M | vs CBIO |
| NGNENeurogene Inc. | 25.87 | +1.65% | $517.69M | vs CBIO |
| MPLTMapLight Therapeutics Inc. | 9.36 | -3.41% | $520.19M | vs CBIO |
| OCSOculis Holding AG | 8.50 | -2.52% | $523.50M | vs CBIO |